Xaira Therapeutics
South San Francisco
About Xaira Therapeutics
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence to learn the language of life and transform how we treat disease. The company seeks to rethink the drug discovery and development process from end-to-end by bringing together leading talent across three core areas: machine learning research to better understand biology, expansive data generation to power new models, and robust therapeutic product development to treat disease. Xaira is headquartered in the San Francisco Bay Area.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $1.0B
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2024)
- Website: xaira.net
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/xaira-therapeutics-103187 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.